• linkedin
  • Increase Font
  • Sharebar

    Prostate Ca study reveals more evidence of racial disparity

    Results of a recently published retrospective study investigating receipt of definitive therapy for intermediate/high-risk localized prostate cancer provide further evidence of racial disparity in prostate cancer favoring Caucasian men compared with African-American men.

    The research also showed the racial difference existed at the facility level and that non-clinical factors, such as hospital type and geographic region, are driving the discrepancy.

    “It is well established that prostate cancer incidence and overall outcomes remain worse for black men. Yet, the precise etiology of this discrepancy remains unclear. We felt that identifying potentially modifiable non-clinical factors contributing to this disparity, such as facility type, represented a timely topic in the setting of recent health reforms that aim to standardize clinical care, such as the Medicare Access and CHIP Reauthorization Act,” said lead author David F. Friedlander, MD, MPH, of Harvard Medical School, Boston.

    Also see: Quality initiative could reduce unnecessary PCa bone scans

    “Therefore, the subgroup analysis performed in our study is particularly noteworthy because it demonstrated that the magnitude of racial variation varied according to both clinical and non-clinical factors, demonstrating the important interplay between sociodemographic and clinical factors with regards to clinical outcomes,” he told Urology Times.

    Dr. Friedlander pointed out that the findings have implications for clinicians.

    “While our study does not explicitly explore the influence of patient preferences or cultural beliefs, it is reasonable to infer from our findings that potentially modifiable non-clinical factors, such as the patient-provider relationship, may at least partially explain the inferior outcomes seen among black men with prostate cancer. Consequently, urology providers should take it upon themselves to recognize these potential barriers to delivering high-quality care to black patients and devise clinical interventions aimed at overcoming these impediments,” said Dr. Friedlander, who worked on the study with Quoc-Dien Trinh, MD, and colleagues.

    Next: What the authors found


    You must be signed in to leave a comment. Registering is fast and free!

    All comments must follow the ModernMedicine Network community rules and terms of use, and will be moderated. ModernMedicine reserves the right to use the comments we receive, in whole or in part,in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.

    • No comments available